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Abstract
Background: During pressure overload-induced hypertrophy, unloading-induced atrophy, and diabetes mellitus, the heart 
induces ‘fetal’ genes (e.g. myosin heavy chain β; mhcβ). 
Hypothesis: We propose that altered glucose homeostasis within the cardiomyocyte acts as a central mechanism for the 
regulation of gene expression in response to environmental stresses. The evidence is as follows. 
Methods and Results: Forced glucose uptake both ex vivo and in vivo results in mhc isoform switching. Restricting dietary 
glucose prevents mhc isoform switching in hearts of both GLUT1-Tg mice and rats subjected to pressure overload-induced 
hypertrophy. Thus, glucose availability correlates with mhc isoform switching under all conditions investigated. A potential 
mechanism by which glucose affects gene expression is through O-linked glycosylation of speciﬁ  c transcription factors. 
Glutamine:fructose-6-phosphate amidotransferase (GFAT) catalyzes the ﬂ  ux generating step in UDP-N-acetylglucosamine 
biosynthesis, the rate determining metabolite in protein glycosylation. Ascending aortic constriction increased intracellular 
levels of UDP-N-acetylglucosamine, and the expression of gfat2, but not gfat1, in the rat heart. 
Conclusions: Collectively, the results strongly suggest glucose-regulated gene expression in the heart, and the involvement 
of glucose metabolites in isoform switching of sarcomeric proteins characteristic for the fetal gene program.
Keywords: Heart, Glucose Metabolism, Fetal Gene Program
Introduction
The heart adapts to changes in its physiologic environment, initially through alterations in the activity 
state and/or locality of pre-existing proteins within the cardiomyocyte. Chronic activation of intracel-
lular signaling cascades affect the levels of speciﬁ  c proteins in the cell, through transcriptional, trans-
lational and post-translational mechanisms. For example, increased workload acutely increases 
glycogenolysis, glucose transport, and lactate oxidation, with a lesser effect on fatty acid oxidation 
(Goodwin et al. 1998). Persistence of pressure overload on the heart results in sustained alterations in 
metabolism as a consequence of changes in the expression of proteins involved in glucose and fatty 
acid utilization (Allard et al. 1994).
Sustained pressure overload not only affects substrate preference, but also leads to a remodeling of 
the heart. Cardiomyocytes increase in size (hypertrophy), together with alterations in the expression of 
multiple myocardial genes (Kleinman et al. 1978; Sugden and Clerk, 1998). In the latter case, the 
hypertrophied heart reverts to a fetal pattern of gene expression, wherein various fetal genes are induced 
with a concomitant repression of adult genes (Komuro and Yazaki, 1993; Depre et al. 1998). One 
example is the switching of mhc isoforms, in which mhcβ (the fetal isoform) is induced, while mhcα 
(the adult isoform) is repressed in the hypertrophied rat heart (Depre et al. 1998; Mercadier et al. 1981). 252
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The exact mechanism(s) by which this isoform 
switching occurs is (are) not known. It is an intrigu-
ing observation that sustained decreases in work 
load or sustained changes in the metabolic milieu 
(e.g. insulin deﬁ  cient diabetes mellitus) induce a 
similar patter of isoform switching (Depre et al. 
1998; Dillmann, 1980; Depre et al. 2000).
The purpose of the present study was to explore 
the hypothesis that substrate metabolism and/or 
intracellular metabolites are responsible for mhc 
isoform switching in the heart in response to 
stimuli such as pressure overload. More speciﬁ  -
cally, we hypothesized that accumulation of intra-
myocellular glucose metabolites drives mhc 
isoform switching in the hypertrophied heart. This 
hypothesis was investigated by: 1) increasing glu-
cose inﬂ  ux into the heart ex vivo; 2) increasing 
glucose inﬂ  ux into the heart in vivo; 3) attenuating 
increased glucose inﬂ  ux by the heart during pres-
sure overload-induced hypertrophy in vivo; and 
4) investigating potential glucose sensing compo-
nents in both the normal and pressure overloaded 
heart. The results are consistent with the notion 
that alterations in glucose metabolism play a role 
in mhc isoform switching.
Methods
Animals and dietary interventions
Rats: Male Spraque-Dawley rats were kept in the 
Animal Care Center of the University of Texas-
Houston Medical School. Mice: Male wild-type 
and MHCα-GLUT1 transgenic littermates with 
cardiac-speciﬁ  c overexpression of GLUT1 were 
kept in the Animal Resource Facility at Harvard 
Medical School. All rodents were housed under 
controlled conditions (23 ± 1 
oC; 12 h light/12 h 
dark cycle) and received chow and water ad libi-
tum. The investigations conformed to the Guide 
for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1996).
Rodents were fed one of three isocaloric diets; 
standard laboratory chow (Purina), a high carbo-
hydrate/low fat diet (HC/LF; Research Diets Inc., 
New Brunswick, NJ), or a low carbohydrate/
high fat diet (LC/HF; Research Diets Inc., New 
Brunswick, NJ). Because the latter two diets were 
isocaloric, they varied only in the proportion of 
energy obtained from carbohydrate and fat. For the 
rat studies, the contribution of carbohydrate, fat 
and protein to total energy available were 71%, 6% 
and 23% for the HC/LF diet, and 24%, 53% and 
23% for the LC/HF diet, respectively. For the 
mouse studies, the contribution of carbohydrate, 
fat and protein to total energy available were 70%, 
10% and 20% for the HC/LF diet, and 20%, 60% 
and 20% for the LC/HF diet, respectively. The fat 
component consisted chieﬂ  y of lard (saturated, 
long-chain fatty acids). All other animals were fed 
the standard laboratory chow.
Working heart ex vivo
Isolated rat hearts were perfused for 90 min in the 
working mode (15 cm H2O preload/100 cm H2O 
afterload) with Krebs-Henseleit buffer contain-
ing β-hydroxybutyrate (10 mM), acetoacetate 
(1 mM) and propionyl-L-carnitine (2 mM). In 
certain experiments, glucose (25 mM) was added 
to the perfusate. Mannitol (25 mM) was added to 
the perfusate when glucose was absent. A physi-
ologic concentration of insulin (40 µU/ml; Lilly) 
was included in all perfusions. At the end, hearts 
were freeze-clamped and stored in liquid nitrogen. 
This method has been described in detail elsewhere 
(Taegtmeyer et al. 1980).
Ascending aortic constriction in vivo
Cardiac pressure overload was induced by constric-
tion of the ascending aorta (Kleinman et al. 1978). 
In control animals, sham operations were per-
formed. During the seven days before surgery, the 
animals received either standard laboratory chow 
(control diet), the HC/LF diet, or the LC/HF diet. 
Speciﬁ  c feeding was maintained until the comple-
tion of the experiment (i.e. isolation of hearts), 
either nine days (HC/LF and LC/HF feeding stud-
ies) or seven weeks (standard laboratory chow 
studies) after surgery. The effects of banding and 
altered dietary fat content on body weight and heart 
weight are shown in Table 1.
RNA isolation and quantitative 
RT-PCR
RNA extraction and quantitative RT-PCR of sam-
ples was performed using previously described 
methods (Depre et al. 1998; Chomczynski and 
Sacchi 1987; Gibson et al. 1996). Speciﬁ  c quantita-
tive assays were designed for mhcα, mhcβ, gfat1, 
gfat2, glucose 6-phosphate dehydrogenase (g6pdh), 
and transketolase (tkl ) using rat and mouse 253
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sequences available in GenBank (Table 2). Primers 
and probes were designed from non-conserved 
sequences of the genes (allowing for isoform 
speciﬁ  city), spanning sites where two exons join 
(splice sites), preventing recognition of the assay 
to any potential contaminating genomic DNA. 
Standard RNA was made for all assays by the T7 
polymerase method (Ambion, Austin, Texas), using 
total RNA isolated from rat hearts. The correlation 
between the Ct (the number of PCR cycles required 
for the ﬂ  uorescent signal to reach a detection thresh-
old) and the amount of standard was linear over at 
least a 5-log range of RNA for all assays (data not 
shown). PCR data are reported as the number of 
mRNA transcripts per ng total RNA.
UDP-N-Acetylglucosamine
The levels of UDP-N-acetylglucosamine, the 
major end product of the hexosamine biosynthetic 
pathway, were measured in perchloric acid 
extracts of rat heart homogenates using high-
performance liquid chromatography and spectro-
photometry as previously described (Veerababu 
et al. 2000).
Xylulose 5-Phosphate
Myocardial levels of the pentose phosphate path-
way (PPP) intermediate xylulose 5-phosphate were 
measured using a spectrophotometric assay similar 
to that described previously for the liver (Casazza 
and Veech, 1986). Brieﬂ  y, deproteinized heart 
samples were prepared by homogenizing approx-
imately 400 mg of powdered heart with 5.6% 
perchloric acid (2 mls). Following neutrilization, 
xylulose 5-phosphate levels were measured in 
PCA extracts by following NADH generation via 
the combined transketolase and glyceraldehyde 
3-phosphate dehydrogenase reactions.
Table 1. Effects of banding and altered dietary fat content on body weight (BW), heart weight (HW), hypertrophy 
(HW/BW ratio).
 HC/LF  HC/LF  LC/HF  LC/HF
 Sham  Banded  Sham  Banded
Body Weight (g)   255 ± 7   257 ± 6   267 ± 6   262 ± 6
Heart Weight (g)  0.81 ± 0.03  0.99 ± 0.09*  0.85 ± 0.02  1.02 ± 0.07
†
HW/BW (×100) 3.16  ± 0.08  3.91 ± 0.24*  3.17 ± 0.07  3.90 ± 0.13
†
Values are shown as the mean ± S.E.M. for between ﬁ  ve and ten separate observations.
*, p   0.05 versus HC/LF sham.
†, p   0.05 versus LC/HF banded.
Table 2. Primer and probe sequences used in real time quantitative RT-PCR.
Gene Primer/Probe  Sequence
mhcα Forward  5′-TGAAAAGATTAACCGGAGTTTAAGA-3′ 
 Reverse  5′-CAGGCACGAAGCACTCTGTG-3′
 Probe  5′-FAM-CCIAAGTCAGCCATCTGGGCATC-TAMRA-3′
mhcβ Forward  5′-TCCTCCCTCAAGCTCCTAAGTAA-3′
 Reverse  5′-TTTGCCTTTGCCCTTGTCTA-3′
 Probe  5′-FAM-CATCAGCICCAGCATAGTTGGCAAACA-TAMRA-3′
gfat1 Forward  5′-GCCGAGCTGTGCAAACTCT-3′
 Reverse  5′-GGCTGCTCAAAAATTTCCTTC-3′
 Probe  5-′FAM-CTCCAGCAGATCATGAAGGGCAACTTTAGT-TAMRA-3′
gfat2 Forward  5′-GCCAGTTCATCTCTCTGGTGC-3′
 Reverse  5′-ATCTGAGGCCACGGATGAT-3′
 Probe  5′-FAM-TGGTTTGATGATGTCTGAAGATCGAATTTCTC-TAMRA-3′
g6pdh Forward  5′-GGGCAAAGAGATGGTCCAG-3′
 Reverse  5′-TCGATTCCAGATGGGTCCA-3′
 Probe  5′-FAM-AGATCCTGTTGGCAAATCTCAGCACCA-TAMRA-3′
tkl Forward  5′-CGAAACCCTCACAATGATCG-3′
 Reverse  5′-AGCTTCAGCCCAGACTGCA-3′
 Probe  5′-FAM-TTTGTGCTCTCCAAGGGCCATGC-TAMRA-3′254
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Statistical analysis
Data are presented as the mean ± SEM for between 
four and ten hearts in each group. Statistically 
signiﬁ  cant differences between groups were cal-
culated by analysis of variance (ANOVA). A value 
of p   0.05 was considered signiﬁ  cant.
Results
Glucose induces mhc isoform 
switching ex vivo
To determine whether glucose induced mhc 
isoform switching in hearts under controlled 
conditions ex vivo, the isolated working rat heart 
preparation was utilized. Working rat hearts from 
animals fed a standard laboratory chow diet were 
perfused either in the absence or presence of 
glucose (25 mM). In the former case, mannitol 
(25 mM) was added to the perfusate to allow for 
any osmotic effects of glucose on heart function 
and/or gene expression. A trend for lower levels of 
mhcα mRNA was observed for hearts perfused in 
the presence of glucose compared to those perfused 
in the presence of mannitol, although this did not 
reach statistical signiﬁ  cance (Fig. 1A). However, 
mhcβ mRNA levels were signiﬁ  cantly elevated 
in hearts perfused with glucose, compared to 
those perfused with mannitol (Fig. 1B). The 
mhcα/mhcβ ratio (a marker of isoform switching) 
was signiﬁ  cantly lower in glucose-perfused hearts 
(Fig. 1C).
Glucose induces mhc isoform 
switching in vivo
To investigate whether glucose induced mhc 
isoform switching occurs in vivo, we utilized mice 
with a cardiomyocyte-speciﬁ  c overexpression of 
the glucose transporter GLUT1; hearts from these 
mice, which have been characterized previously 
(Luptak et al. 2007), do not exhibit contractile 
dysfunction. Hearts isolated from transgenic 
mice fed the HC/LF diet exhibit signiﬁ  cantly 
lower mhcα expression, with a concomitant 
greater mhcβ expression, compared to hearts 
isolated from wild-type littermates, fed the same 
diet (Figs. 2A-2B). Feeding mice the LC/HF diet 
prevented this isoform switching; mhcα expres-
sion was not signiﬁ  cantly different between wild-
type and transgenic mice fed the LC/HF diet, 
whereas mhcβ was signiﬁ  cantly lower in hearts 
isolated from transgenic versus wild-type 
mice fed the LC/HF diet (Fig. 2B). As such, mhc 
isoform switching (mhcα/mhcβ ratio) observed 
for hearts isolated from transgenic mice was 
prevented when mice were fed the LC/HF diet 
(Fig. 2C).
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Figure 1. Effects of glucose on mhcα (A) and mhcβ (B) expression, as well as the mhcα/mhcβ ratio (C), in the perfused working rat heart. 
Hearts were perfused for 90 minutes in Krebs-Henseleit buffer containing β-hydroxybutyrate (10 mM), acetoacetate (1 mM), propionyl-L-
carnitine (2 mM) and insulin (40 µUnits/ml), without (control) or with glucose (25 mM). Control hearts were also perfused in the presence of 
mannitol (25 mM). Values are shown as the mean ±S.E.M. for four separate observations.
*, p   0.05.255
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Limiting dietary carbohydrate 
availability prevents mhc isoform 
switching in response to pressure 
overload
We have shown before that nine days of aortic 
constriction induces left ventricular hypertrophy 
in rats fed either HC/LF or LC/HF diet (i.e. diet-
independent); diet alone had no effects on body 
weight, or heart weight (Young et al. 2001b). The 
same was the case in the present study (Table 1).
Aortic constriction of animals placed on the 
HC/LF diet resulted in decreased mhcα mRNA 
levels (Fig. 3A), and a concomitant increase in 
mhcβ mRNA levels (Fig. 3B). This isoform 
switching was not observed in response to pressure 
overload when rats were placed on the LC/HF diet 
(Figs. 3A-3B). Diet alone had no effects on MHC 
isoform expression in the heart (Figs. 3A-3B, 
black columns). As such, pressure overload-
induced mhc isoform switching (as indicated by 
the mhcα/mhcβ ratio) was prevented when rats 
were fed the LC/HF diet (Fig. 3C). We also mea-
sured transcript levels of the “fetal” genes basic 
ﬁ  broblast growth factor (bfgf) and skeletal α-actin 
(sk α-actin) (Figs. 3D-3E). Like the transcript 
levels of MHCβ, pressure overload-mediated 
induction of these two transcripts was attenuated 
when rats were fed the LC/HF diet.
Sustained pressure overload 
activates the hexosamine biosynthetic 
pathway
To investigate whether increased ﬂ  ux through 
the hexosamine biosynthetic pathway occurs in 
response to pressure overload in the heart, we 
measured: 1) the expression of two isoforms of 
GFAT (glutamine fructose 6-phosphate amido-
transferase, gfat1 and gfat2) which catalyzes the 
ﬂ  ux generating step in this pathway; and 2) UDP-N-
acetylglucosamine, the principal end-product of 
this pathway, in control as well as in hypertrophied 
hearts (Veerababu et al. 2000; Yki-Jarvinen et al. 
1998; Rossetti et al. 1995).
Ascending aortic constriction for seven weeks 
induced hypertrophy (heart-to-body weight 
ratios 2.84 ± 0.02 vs 3.69 ± 0.05, control vs banded; 
p   0.001). The level of gfat1 expression was not 
signiﬁ  cantly different between the control and 
hypertrophic hearts (Fig. 4A). In contrast, 
the level of gfat2 mRNA was 38% higher in 
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Figure 2. Effects of altered dietary carbohydrate and fat availability 
on mhcα (A) and mhcβ (B) expression, as well as the mhcα/mhcβ 
ratio (C), in wild-type (WT) and GLUT1 transgenic (Tg) hearts. Mice 
were placed on either a high carbohydrate/low fat diet (HC/LF) or a 
low carbohydrate/high fat diet (LC/HF). Values are shown as the 
mean ± S.E.M. for six separate observations.
*, p   0.05, and **, p   0.01 versus WT.256
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pressure overloaded hearts compared to control 
hearts (Fig. 4B). In addition, pressure overload was 
also associated with a 40% increase in cardiac 
UDP-N-acetylglucosamine levels (Fig. 4C).
No effect of sustained pressure
overload on the pentose phosphate 
pathway
To investigate whether increased ﬂ  ux through the 
pentose phosphate pathway occurs in response to 
pressure overload in the heart, seven weeks after 
aortic constriction we measured in control and hyper-
trophied hearts: 1) the expression of two key enzymes 
in xylulose 5-phosphate biosynthesis, namely g6pdh 
(glucose 6-phosphate dehydrogenase) and tkl (tran-
sketolase); and 2) xylulose 5-phosphate, an important 
regulatory intermediate in this pathway. The results 
indicate that neither the expression of g6pdh nor tkl 
were affected by sustained pressure overload 
(Figs. 4D-4E). Xylulose 5-phosphate levels were 
also not different (Fig. 4F).
Discussion
We provide strong evidence in support of the 
hypothesis that glucose metabolites play a role in 
the adaptation of the myocardium to pressure over-
load, at the level of gene expression. When hearts 
are forced to utilize glucose, both ex vivo (glucose 
perfused hearts) and in vivo (GLUT1 transgenic 
mice), mhc isoform switching is induced. Limiting 
dietary glucose prevents mhc isoform switching in 
both GLUT1 transgenic hearts and pressure 
overload-induced hypertrophied hearts. For poten-
tial mechanisms we focused on the hexosamine 
biosynthetic pathway and the pentose phosphate 
pathway (Fig. 5). Myocardial levels of gfat2 mRNA 
(encoding for a ﬂ  ux generating enzyme in the 
hexosamine biosynthetic pathway) and UDP-N-
acetylglucosamine (the major end-product of this 
pathway) were elevated in response to pressure 
overload. In contrast, no alterations in the expression 
of two key enzymes in the pentose phosphate 
pathway (namely g6pdh and tkl) were observed in 
the hypertrophied heart, nor was there an increase 
in xylulose 5-phosphate levels.
Glucose sensing in the heart
A hallmark of long-term adaptation of the rodent 
heart to environmental stresses is the re-expression 
of a fetal gene program. The predominant isoform 
of myosin heavy chain (mhc) expressed in the fetal 
heart of the rodent is mhcβ. During the ﬁ  rst weeks 
of post-natal life, mhcβ declines and is replaced by 
the adult isoform, mhcα (Schwartz et al. 1992). In 
the presence of chronic stimuli, including pressure 
overload, mechanical unloading or diabetes, the 
heart re-expresses mhcβ with concomitant repres-
sion of mhcα expression (Depre et al. 1998; 
Mercadier et al. 1981). To date, no single pathway 
has been attributed to this isoform switching in the 
heart to these various stimuli.
We propose a unifying hypothesis that is based 
on the following reasoning. Despite the apparent 
opposing metabolic adaptation of the heart to 
alterations in workload and a diabetic milieu, we 
propose that glycolytic intermediates accumulate 
in the heart during both situations due to an imbal-
ance between glucose uptake and phosphorylation 
on the one hand and pyruvate oxidation on the other 
hand (Fig. 5). In the hypertrophied heart (and the 
atrophied and fetal hearts), glucose uptake and 
metabolism are both increased (Allard et al. 1994; 
Doenst et al. 2001). However, the high rate of glu-
cose uptake exceeds the rate of pyruvate oxidation, 
resulting in accumulation of glycolytic intermedi-
ates. A similar scenario may occur for the heart 
during hypoxia, where decreased expression 
of peroxisome proliferator-activated receptor 
α- (PPARα-) regulated genes is associated with 
increased reliance on glucose (Razeghi et al. 2001). 
We designed the experiments with the assumption 
that with LC/HF we signiﬁ  cantly reduced carbohy-
drate availability, although neither blood glucose 
nor insulin levels were measured. Previously pub-
lished studies have shown lower plasma glucose 
and insulin levels in the fed state for rats fed a high 
fat (low carbohydrate) diet (De Gasquet et al. 1977). 
This pattern is markedly different from insulin-
dependent diabetes mellitus, where both glucose 
and fatty acids levels are markedly elevated. In 
contrast to the hypertrophied heart, the diabetic 
heart increases reliance on fatty acids as a fuel. Fatty 
acids inhibit glucose oxidation at the level of the 
pyruvate dehydrogenase complex (PDC) to a 
greater extent than they inhibit glucose uptake. 
Increased mitochondrial acetyl-CoA and NADH 
levels (due to increased fatty acid and ketone body 
utilization) and phosphorylation by PDC kinase 4 
(due to PPARα-mediated induction) jointly inhibit 
PDC (Wu et al. 1999; Randle et al. 1978). Despite 
decreased glucose transporter expression and 
decreased insulin-mediated glucose transport, the 258
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(E), and xylulose 5-phosphate (F) levels in the heart. Values are shown as the mean ±S.E.M. for six to twenty-four separate observations.
*, p   0.05 and ***, p   0.001.259
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rates of glucose uptake in the diabetic environment, 
are comparable to those observed in normal hearts, 
due to the prevailing hyperglycemia (Ungar et al. 
1955). Thus, with normal glucose inﬂ  ux into the 
cardiomyocyte, and the block at PDC, glucose 
metabolites accumulate. Indeed, intracellular con-
centrations of glucose, glucose 6-phosphate, fruc-
tose 6-phosphate, glycogen, pyruvate and lactate 
have all been shown to be increased in the heart 
during diabetes (Chen et al. 1984; Stroedter et al. 
1995).
Additional evidence exists in support of the 
hypothesis. If the rate of glucose oxidation is 
increased in the pressure overloaded heart, thereby 
re-coupling glycolysis and pyruvate oxidation, 
through treatment of rats with etomoxir, an irre-
versible inhibitor of carnitine palmitoyltransferase I, 
mhc isoform switching is attenuated (Turcani and 
Rupp, 1997). Similar results are observed for the 
heart in diabetes. Myocardial mhc isoform switch-
ing during diabetes is prevented by treatment with 
etomoxir, as well as a second fatty acid oxidation 
inhibitor, methylpalmoxirate (Dillmann, 1985; 
Rupp et al. 1994). It therefore appears that when-
ever there is a loss of coupling between glycolysis 
and pyruvate oxidation, either due to increased 
glucose inﬂ  ux (e.g. fetal, hypertrophied and atro-
phied hearts) and/or inhibition of pyruvate oxida-
tion (e.g. heart in diabetes), mhc isoform switching 
occurs. Glucose sensing may be the common 
mechanism. In addition to the mhc isoforms, the 
expression of various other genes is altered in the 
above situations. For example, skeletal α-actin is 
induced during pressure overload, an effect that is 
abolished when substrate switching is prevented 
(Young et al. 2001a) (Fig. 3E). Furthermore, 
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induction of skeletal α-actin during pressure 
overload is dependent on the activation of Sp1, a 
transcription factor that is known to be activated 
in response to increased glucose availability in liver 
(Karns et al. 1995). More recently the nuclear 
receptor LXR has been identiﬁ  ed as a glucose sen-
sor in the lever as well (Mitro et al. 2007). In this 
tissue, LXR serves as a switch for the integration 
of various metabolic pathways.
While fatty acids are able to modulate gene 
expression in the heart, most likely through activa-
tion of the nuclear receptor PPARα, (Barger and 
Kelly, 2000) nothing is known concerning glucose-
regulated gene expression in the heart. Extensive 
work in liver suggests the involvement of two 
major pathways in the sensing of glucose avail-
ability, namely the hexosamine biosynthetic path-
way and the pentose phosphate pathway (Girard 
et al. 1997; Ferré 1999; Vaulont et al. 2000). The 
present studies provide evidence that glucose sens-
ing occurs in the heart.
Hexosamine biosynthetic pathway
Increased inﬂ  ux of glucose into the cell, and/or 
increased activity of GFAT, results in increased ﬂ  ux 
through the hexosamine biosynthetic pathway 
(Hebert, Jr., et al. 1996). The resultant elevation in 
the principal end-product of this pathway, UDP-
N-acetylglucosamine, is utilized by transferases for 
the O-linked glycosylation of various target proteins 
(Wells et al. 2001). Such O-linked glycosylation 
of signaling proteins occurs at serine and threo-
nine residues otherwise utilized as regulatory 
phosphorylation sites, a mechanism similar to 
phosphorylation in that it is a reversible covalent 
modiﬁ  cation that affects the activity of the target 
protein (Wells et al. 2001). However, unlike phos-
phorylation, the rate of O-linked glycosylation is 
dependent on intracellular levels of the linkage 
group donor (i.e. UDP-N-acetylglucosamine, which 
in turn is dependent upon the inﬂ  ux of glucose into 
the cell, and/or increased activity of GFAT).
Proteins known to be activated by O-linked 
glycosylation include the transcription factors 
c-myc and Sp1, both of which are activated during 
pressure overload (Karns et al. 1995; Wells et al. 
2001; Izumo et al. 1988). O-glycosylation of Sp1 
is already known for quite some time (Jackson and 
Tjian, 1988). The present study shows that UDP-
N-acetylglucosamine levels were significantly 
elevated in pressure overloaded hearts (Fig. 4C). 
It is reasonable to assume that this increase is due 
to both increased expression of gfat2 (Fig. 4B), as 
well as increased inﬂ  ux of glucose into the cell. 
We speculate that c-myc and/or Sp1 activation in 
the heart during pressure overload may be due, at 
least in part, to increased O-linked glycosylation. 
Thus, altered glucose metabolism would contribute 
toward early molecular events involved in remod-
eling of the heart during pressure overload and the 
return to the fetal gene program (Sugden and Clerk, 
1998; Komuro and Yazaki, 1993; Depre et al. 1998; 
Mercardier et al. 1981; Dillmann, 1980; Depre 
et al. 2000).
Pentose phosphate pathway
We have previously shown appreciable ﬂ  ux through 
the non-oxidative branch of the PPP in the heart 
(Goodwin et al. 2001). However, neither the 
expression of key enzymes involved in this path-
way (g6pdh and tkl), nor the levels of xylulose 
5-phosphate, were altered in the heart after seven 
weeks of pressure overload (Figs. 4D-4F). This 
suggests that the pentose phosphate pathway may 
not play a major role in adaptation of the heart 
to sustained pressure overload. Still, this path-
way may be important for acute adaptation to 
stimuli such as ischemia, when glycolytic interme-
diates accumulate rapidly. It is certainly important 
in the liver, where the signaling molecule xylulose 
5-phospthate triggers rapid changes in the nuclear 
import of the transcription factor carbohydrate 
response element binding protein (ChREBP) which 
coordinates the transcriptional regulation of meta-
bolic enzymes (Uyeda and Repa, 2006). The role 
of ChREBP in the heart remains unknown.
Conclusions
We have found evidence in support of the hypoth-
esis that alterations in metabolism are involved in 
the adaptation of the heart to environmental 
stresses, such as pressure overload, at least at the 
level of gene expression. Increased O-linked 
glycosylation of proteins may play signiﬁ  cant 
roles in the adaptation of the heart, in addition to 
transcriptional alterations, such as translational 
initiation (through eIF-2) or post-translational 
modulation of enzymatic activity (e.g. glycogen 
synthase) or cellular signaling (e.g. insulin signal-
ing) (Datta et al. 1989; Crook et al. 1995; Patti et al. 
1999). Glucose sensing may therefore play a role 261
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in the adaptation of the myocardium to various 
stimuli, whether they are hemodynamic (e.g. 
increased workload) or metabolic (e.g. diabetes).
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